非ST段抬高型心肌梗死患者介入治疗时机的选择临床分析

Clinical analysis of the choice of intervention time for non-ST-segment elevation myocardial infarction

目的探讨不同类型非ST段抬高型心肌梗死(non-ST segment elevated myocardial infarction,NSTEMI)患者可靠临床治疗时机。方法选取该院收治的NSTEMI患者228例为研究对象,按照患者合并症情况进行分组,分成高血压组(110例)和糖尿病组(118例),比较两组患者采用不同治疗时机后的相关临床情况。结果合并糖尿病的NSTEMI患者中,早期介入治疗组患者平均血糖水平较高(P<0.05)。在再发心绞痛、再发心肌梗死、心衰等不良心脏事件发生情况上,合并高血压NSTEMI患者中早期介入治疗组优于择期介入治疗组(均P<0.05);合并糖尿病NSTEMI患者中早期介入治疗组效果差于择期介入治疗组,且差异均具有显著性(均P<0.05)。结论在临床针对非ST段抬高型心肌梗死患者实施介入治疗的过程中,对于合并高血压的患者应实施早期介入治疗,对于合并糖尿病的患者应实施择期介入治疗更可靠。

[Objective ] To investigate thereliable clinical treatment opportunity of different types of non-ST- seg- ment elevated myocardial infarction （NSTEMI）. [ Methods ] 228 cases with non-ST segment elevated myocardial in- farction in our hospital were grouped into the hypertension group （110 cases） and the diabetes group （118 cases） in accordance with complications conditions. The clinical situation of the two groups with different time was taken for comparative study. [ Results ] The blood glucose levels of early intervention subgroup in diabetic group were higher than that in elective intervention subgroup. The recurrent angina, recurrent myocardial infarction, heart failure and other conditions on the occurrence of adverse cardiac eventswerecompared between the two groups, the early inter- vention subgroup in hypertension groups were better than that in elective intervention subgroup （P 〈0.05）; the early intervention subgroup in diabetes groups were worse than that in elective intervention subgroup, and the difference were statistically significant（P 〈0.05）. [ Conclusions] In clinical treatment procedure for NSTEMI cases, the patients with hypertension should be implemented early intervention therapy, the patients with diabetes should be implement- ed elective interventional treatment.